Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection
- PMID: 30032272
- PMCID: PMC6306014
- DOI: 10.1093/infdis/jiy445
Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection
Figures
Comment on
-
The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis.J Infect Dis. 2019 Jan 7;219(2):254-263. doi: 10.1093/infdis/jiy442. J Infect Dis. 2019. PMID: 30032171 Free PMC article.
References
-
- The Lancet HIV. U = U taking off in 2017. Lancet HIV 2017; 4:e475. - PubMed
-
- Rodger AJ, Cambiano V, Bruun T, et al. . Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 2016; 316:171–81. - PubMed
-
- Iwuji CC, Orne-Gliemann J, Larmarange J, et al. . Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV 2018: 5:e116–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
